Service agreement for the viia 7 real-time PCR
Ended Awarded Last action
- Contract number
- 75N91023F00011
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,909
Award facts
- Contract value 100% obligated
- $22,908.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
About this award
Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a $22,908.76 firm fixed-price Blanket Purchase Agreement (BPA) call from the National Cancer Institute on April 16, 2023, for a service agreement related to the VIIA 7 real-time polymerase chain reaction (PCR) system. The contract, which was completed by April 15, 2024, will be performed in Rockville, Maryland. No set-aside designation was used in this award. Life Technologies Corporation is a leading provider of scientific instruments and reagents to federal agencies, and this contract represents a task order under an existing BPA vehicle, enabling streamlined procurement of maintenance or support services for the advanced PCR platform used in the National Cancer Institute's research operations.
The National Cancer Institute, part of the National Institutes of Health, supports cancer research and diagnostics requiring sophisticated laboratory instrumentation. This contract award reflects the Institute's continued reliance on specialized scientific equipment providers to maintain its research capabilities. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, has an established history of supplying complex laboratory instruments and technical support services to federal health agencies. The modest contract ceiling value suggests this BPA call likely covers preventative maintenance, technical support, or consumable services for the existing VIIA 7 real-time PCR instrumentation rather than capital equipment procurement.
Quick answers
Who was awarded contract 75N91023F00011?
75N91023F00011 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on April 16, 2023.
How much is contract 75N91023F00011 worth?
The government has obligated $22,909 on 75N91023F00011.
Is contract 75N91023F00011 an order under another contract?
Yes. 75N91023F00011 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91023F00011 competed?
The extent of competition for 75N91023F00011 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award